Literature DB >> 32272085

Economic sanctions and Iran's capacity to respond to COVID-19.

Adrianna Murphy1, Zhaleh Abdi2, Iraj Harirchi3, Martin McKee1, Elham Ahmadnezhad4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32272085      PMCID: PMC7270502          DOI: 10.1016/S2468-2667(20)30083-9

Source DB:  PubMed          Journal:  Lancet Public Health


× No keyword cloud information.
Iran was one of the first countries outside China to have a rapid increase in the number of cases of coronavirus disease 2019 (COVID-19). The country's capacity to respond to the virus is substantially impeded by unilateral economic sanctions re-imposed after the US Administration withdrew from the nuclear deal in May, 2018, and further US sanctions imposed as recently as March 18, 2020. As of March 31, 2020, the recorded number of people infected from COVID-19 in Iran was 41 495, with 2757 deaths, but these numbers are likely a substantial underestimation. Even before COVID-19, Iran's health system was feeling the effect of the sanctions. Their impact is now severe because they restrict the government's ability to raise funds or to import essential goods. Of the ten countries with the highest number of recorded cases of COVID-19 to date, Iran is the poorest. In 2019, Iran had the lowest rate of economic growth (–9·5%) and highest rate of inflation (35·7%) recorded in the country for the past 20 years. This financial situation makes the funding of adequate prevention, diagnosis, and treatment of COVID-19 impossible, and the country cannot take the same measures adopted in other countries to strengthen responses, such as paying the full cost of obtaining treatment. Essential medicines and medical equipment are technically exempt from sanctions, but their availability is restricted by the effect of sanctions on the commercial sector, reducing manufacturing and trade capacity, and on foreign exchange. Consequently, although approximately 184 000 hospital and primary health-care staff are working to fight COVID-19, their efforts are thwarted by shortages of test kits, protective equipment, and ventilators. WHO has provided crucial supplies, sufficient equipment for 31 000 workers, but supplies are still substantially short of what is needed. The COVID-19 pandemic has occurred at a time of economic crisis in Iran, in which steep increases in medicine price have affected approximately 6 million patients with complex and chronic illnesses; the situation is almost certainly worse now. This group of individuals is at particularly high risk of infection and disease progression. As stated by the Director-General of WHO, “We're all in this together, and we can only save lives together.” He was clear that the pandemic caused by COVID-19, the spread of which is unaffected by national borders, can only be controlled by extraordinary co-operation between countries, putting political differences aside. Like elsewhere, delays in implementing strict physical distancing measures in Iran have likely made management of the increasing number of COVID-19 cases more difficult, but the impact of sanctions on the country's capacity to take these measures should not be ignored. Some countries (such as the UK) and some political leaders (including some in the USA), have recognised the urgent need to ease US sanctions on Iran. But the call to do so has achieved little global traction and time is running out. The Organisation for Economic Co-operation and Development forecasts that global economic growth could decrease by 0·5–1·4% due to COVID-19. The harsh obstacles presented by US sanctions mean that Iran could bear a disproportionate share of this fiscal and health shock, leading to its probable economic collapse and inability to contain the virus that has implications for the entire world.
  2 in total

1.  The harsh effects of sanctions on Iranian health.

Authors:  Goodarz Danaei; Iraj Harirchi; Haniye Sadat Sajadi; Faeze Yahyaei; Reza Majdzadeh
Journal:  Lancet       Date:  2019-08-08       Impact factor: 79.321

2.  Health care: Medical supplies in Iran hit by sanctions.

Authors:  Ali Gorji
Journal:  Nature       Date:  2013-03-21       Impact factor: 49.962

  2 in total
  17 in total

1.  Machine Learning Models to Predict In-Hospital Mortality among Inpatients with COVID-19: Underestimation and Overestimation Bias Analysis in Subgroup Populations.

Authors:  Javad Zarei; Amir Jamshidnezhad; Maryam Haddadzadeh Shoushtari; Ali Mohammad Hadianfard; Maria Cheraghi; Abbas Sheikhtaheri
Journal:  J Healthc Eng       Date:  2022-06-23       Impact factor: 3.822

2.  Awareness, attitude, and perceived anxiety about COVID-19 in the Iranian population: A cross-sectional questionnaire survey.

Authors:  Mahsa Ghasemi; Deblina Roy; Mina Shabani; Nitika Singh; Reza Pirzeh; Sujita Kumar Kar
Journal:  Int Soc Sci J       Date:  2022-04-04

3.  The mental health impact of COVID-19 outbreak: a Nationwide Survey in Iran.

Authors:  Reza Shahriarirad; Amirhossein Erfani; Keivan Ranjbar; Amir Bazrafshan; Alireza Mirahmadizadeh
Journal:  Int J Ment Health Syst       Date:  2021-02-27

4.  Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future.

Authors:  Brian Godman; Mainul Haque; Salequl Islam; Samiul Iqbal; Umme Laila Urmi; Zubair Mahmood Kamal; Shahriar Ahmed Shuvo; Aminur Rahman; Mustafa Kamal; Monami Haque; Iffat Jahan; Md Zakirul Islam; Mohammad Monir Hossain; Santosh Kumar; Jaykaran Charan; Rohan Bhatt; Siddhartha Dutta; Jha Pallavi Abhayanand; Yesh Sharma; Zikria Saleem; Thuy Nguyen Thi Phuong; Hye-Young Kwon; Amanj Kurdi; Janney Wale; Israel Sefah
Journal:  Front Public Health       Date:  2020-12-14

5.  Mental health status during COVID-19 pandemic in Fars Province, Iran: timely measures.

Authors:  Arash Mani; Ali Reza Estedlal; Mahsa Kamali; Seyede Zahra Ghaemi; Leila Zarei; Nasrin Shokrpour; Seyed Taghi Heydari; Kamran Bagheri Lankarani
Journal:  BMC Public Health       Date:  2020-12-07       Impact factor: 3.295

6.  The Social Consequences of the Novel Coronavirus Disease (COVID-19) Outbreak in Iran: Is Social Capital at Risk? A Qualitative Study.

Authors:  Mohadeseh Motamed-Jahromi; Mohammad Hossein Kaveh
Journal:  Interdiscip Perspect Infect Dis       Date:  2021-06-10

7.  Latent Cultural Bias in Soundtracks of Western News Coverage From Early COVID-19 Epicenters.

Authors:  James Deaville; Chantal Lemire
Journal:  Front Psychol       Date:  2021-07-14

8.  The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Authors:  Milad Haghani; Michiel C J Bliemer; Floris Goerlandt; Jie Li
Journal:  Saf Sci       Date:  2020-05-07       Impact factor: 6.392

9.  Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs.

Authors:  Maryam Alavi; Amir Moghanibashi-Mansourieh; Seyed Ramin Radfar; Sepideh Alizadeh; Fatemeh Bahramabadian; Sara Esmizade; Gregory J Dore; Farid Barati Sedeh; Abbas Deilamizade
Journal:  Int J Drug Policy       Date:  2020-08-17

10.  Assessing Iran's health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications.

Authors:  Mahboubeh Khaton Ghanbari; Masoud Behzadifar; Ahad Bakhtiari; Meysam Behzadifar; Samad Azari; Hasan Abolghasem Gorji; Saeed Shahabi; Mariano Martini; Nicola Luigi Bragazzi
Journal:  J Prev Med Hyg       Date:  2021-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.